Vascular endothelial growth factors in retinal and choroidal neovascular diseases (Q37834016)

24 August 2017

1 reference

title

Vascular endothelial growth factors in retinal and choroidal neovascular diseases (English)

1 reference

24 August 2017

0 references

2

1 reference

24 August 2017

1

Kati Kinnunen

1 reference

PubMed ID

21284527

24 August 2017

language of work or name

English

0 references

publication date

1 February 2011

1 reference

24 August 2017

1 reference

24 August 2017

44

1 reference

24 August 2017

1

1 reference

24 August 2017

1-17

1 reference

Risk factors for age-related macular degeneration: Pooled findings from three continents.

24 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Vascular endothelial growth factor B, a novel growth factor for endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Snake Venom Vascular Endothelial Growth Factors (VEGFs) Exhibit Potent Activity through Their Specific Recognition of KDR (VEGF Receptor 2)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

A novel type of vascular endothelial growth factor, VEGF-E (NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

The vascular endothelial growth factor family of polypeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Histopathology and vascular endothelial growth factor in untreated and diode laser-treated retinopathy of prematurity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

The biology of VEGF and its receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

VEGF expression and receptor activation in the choroid during development and in the adult.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Time-course expression of vascular endothelial growth factor as related to the development of the retinochoroidal vasculature in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Vascular endothelial growth factor-B and retinal vascular development in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Proteolytic processing regulates receptor specificity and activity of VEGF-C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Vascular endothelial growth factor C induces angiogenesis in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Hyperplasia of lymphatic vessels in VEGF-C transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Differences in retinal neovascular tissue and vitreous humour in patients with type 1 and type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Vascular endothelial growth factor upregulates pigment epithelium-derived factor expression via VEGFR-1 in human retinal pigment epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Vascular endothelial growth factor-B induces myocardium-specific angiogenesis and arteriogenesis via vascular endothelial growth factor receptor-1- and neuropilin receptor-1-dependent mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Differential expression of neuropilin-1 and neuropilin-2 in arteries and veins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Deficiency of neuropilin 2 suppresses VEGF-induced retinal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Selective induction of neuropilin-1 by vascular endothelial growth factor (VEGF): a mechanism contributing to VEGF-induced angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Experimental subretinal neovascularization is inhibited by adenovirus-mediated soluble VEGF/flt-1 receptor gene transfection: a role of VEGF and possible treatment for SRN in age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Early loss of blue-sensitive color vision in patients with type I diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Studies on diabetic retinopathy. 3. Influence of diabetes on intramural pericytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Pathogenetic potential of leukocytes in diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Pericytes and the pathogenesis of diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Diabetes-induced activation of nuclear transcriptional factor in the retina, and its inhibition by antioxidants.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Hyperglycemia, Polyol Metabolism, and Complications of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Nonenzymatic glycosylation and the pathogenesis of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Oxidative stress and diabetic vascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Inhibition of PKC beta by oral administration of ruboxistaurin is well tolerated and ameliorates diabetes-induced retinal hemodynamic abnormalities in patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Effect of oxygen on developing retinal vessels with particular reference to the problem of retrolental fibroplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

The role of apoptosis in age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Colour contrast sensitivity in patients with soft drusen, an early stage of ARM.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Local cellular sources of apolipoprotein E in the human retina and retinal pigmented epithelium: implications for the process of drusen formation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Optical coherence tomography of age-related macular degeneration and choroidal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Basal linear deposit and large drusen are specific for early age-related maculopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

The retinal pigment epithelium in visual function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Lipofuscin of the retinal pigment epithelium: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Lipofuscin is a photoinducible free radical generator.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Senile macular degeneration: a histopathologic study. 1977.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Decreased thickness and integrity of the macular elastic layer of Bruch's membrane correspond to the distribution of lesions associated with age-related macular degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Increased expression of angiogenic growth factors in age-related maculopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Levels of vascular endothelial growth factor are elevated in the vitreous of patients with subretinal neovascularisation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Preclinical pharmacokinetics of Ranibizumab (rhuFabV2) after a single intravitreal administration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Pharmacokinetics and safety of an anti-vascular endothelial growth factor aptamer (NX1838) following injection into the vitreous humor of rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Ranibizumab for neovascular age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration (FOCUS): year 2 results

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in diabetes (READ-2) study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Management of neovascular age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Intravitreal bevacizumab for the treatment of macular oedema secondary to branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Bevacizumab in retinal vein occlusion-results of a prospective case series

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

VEGF-TRAP(R1R2) suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

A phase I study of intravitreal vascular endothelial growth factor trap-eye in patients with neovascular age-related macular degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Sequence- and target-independent angiogenesis suppression by siRNA via TLR3

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Common sequence variation in the VEGFA gene predicts risk of diabetic retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Potential role of the angiopoietin/tie2 system in ischemia-induced retinal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Preclinical evaluation of the novel small-molecule integrin alpha5beta1 inhibitor JSM6427 in monkey and rabbit models of choroidal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Extrapolating anti-vascular endothelial growth factor therapy into pediatric ophthalmology: promise and concern

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

Endogenous VEGF is required for visual function: evidence for a survival role on müller cells and photoreceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.532150

10.3109/07853890.2010.532150

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference

PubMed ID

21284527